FGF-2 regulates cell proliferation, migration, and angiogenesis through an NDY1/KDM2B-miR-101-EZH2 pathway

Filippos Kottakis1, Christos Polytarchou, Parthena Foltopoulou

  • 1Molecular Oncology Research Institute, Tufts Medical Center, Boston, MA 02111, USA.

Molecular Cell
|July 23, 2011
PubMed

Insights

The histone demethylase NDY1 and EZH2 collaborate to suppress miR-101, a key inhibitor of EZH2. This interaction drives oncogenesis and is active in bladder cancer, revealing a novel oncogenic pathway.

Area of Science:

  • Epigenetics
  • Molecular Oncology
  • Cancer Biology

Background:

  • Enhancer of zeste homolog 2 (EZH2) is a histone methyltransferase crucial in oncogenesis.
  • The precise mechanisms underlying EZH2's role in cancer remain incompletely understood.
  • MicroRNAs (miRNAs) are key regulators of gene expression implicated in cancer development.

Purpose of the Study:

  • To elucidate the functional relationship between NDY1, EZH2, and miR-101 in oncogenesis.
  • To identify the molecular pathway linking FGF-2, NDY1, EZH2, and miR-101.
  • To investigate the activity of this pathway in bladder cancer.

Main Methods:

  • Investigated the synergistic action of NDY1 and EZH2 on miR-101 promoter activity.
  • Analyzed the binding of NDY1 and EZH2 to the miR-101 promoter.
  • Examined the induction of NDY1 by FGF-2 and its downstream effects.
  • Assessed the expression and activity of the FGF-2-NDY1/EZH2-miR-101 axis in bladder cancer samples.

Main Results:

  • NDY1 and EZH2 cooperate to repress the transcription of miR-101 by binding its promoter.
  • NDY1 upregulation triggers the concerted action of NDY1 and EZH2, leading to increased EZH2 levels and sustained miR-101 repression.
  • FGF-2 induces NDY1 via CREB phosphorylation, mediating cellular effects on proliferation, migration, and angiogenesis.
  • The identified FGF-2-NDY1/EZH2-miR-101-EZH2 axis is active in bladder cancer.

Conclusions:

  • A novel oncogenic pathway involving FGF-2, NDY1, EZH2, and miR-101 has been delineated.
  • This pathway links FGF-2 signaling to EZH2-mediated gene silencing through NDY1 and miR-101.
  • The findings provide insights into the mechanisms of oncogenesis and potential therapeutic targets in bladder cancer.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.